ADVERTISEMENT

COVID-19: mRNA-1273 vaccine linked to higher rates of myocarditis/pericarditis than BNT162b2 vaccine

Miriam Davis, PhD   |   Clinical Summary   |   29 June 2022
ADVERTISEMENT

Takeaway

  • A population-based study from Ontario, Canada, finds that mRNA-1273’s COVID-19 vaccine is associated with higher rates of myocarditis or pericarditis than BNT162b2’s , especially among young men.
  • A longer interdose interval of ≥56 days is associated with lower rates of pericarditis/myocarditis after both mRNA vaccines.

Why this matters

  • Findings confirm and extend...

          

Topic Challenges

left
right